Navigation Links
BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
Date:4/10/2008

- Strategic Collaboration with the National Cancer Institute's NABTT

Consortium -

BRISBANE, Calif., April 10 /PRNewswire/ -- BiPar Sciences, Inc. today announced the expansion of the clinical program for the company's lead product candidate, BSI-201, into glioblastoma multiforme (GBM), the most common glioma in adults. BSI-201, the first poly ADP-ribose polymerase (PARP) inhibitor in BiPar's DNA repair portfolio, crosses the blood-brain barrier, a unique property that enables its targeted investigation in the brain tumor setting. This study is being conducted by investigators from the New Approaches to Brain Tumor Therapy (NABTT) consortium, a National Cancer Institute-funded research group. In addition to GBM, BiPar is currently enrolling BSI-201 in a randomized Phase 2 trial for triple-negative breast cancer and is initiating Phase 2 trials in uterine and BRCA-negative ovarian cancers.

"We believe a multi-drug strategy is the best approach to battling GBM. There is a significant need for new treatments that can offer GBM patients and their families additional hope," said Stuart A. Grossman, M.D., professor of oncology, medicine and neurological surgery at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital and the co-chairperson for this study.

"BSI-201 is a promising agent that has been well tolerated in combination with cytotoxic therapies in patients with solid tumors and potentially addresses a key pathway by which GBM cells resist the effects of existing medications. We are hopeful that BSI-201 will safely potentiate the power of current therapies for GBM and improve survival in this difficult-to-treat cancer," said Jaishri Blakeley, M.D., Assistant Professor of Neurology, Oncology and Neurosurgery at Johns Hopkins and the study chairperson for this study.

"The scientific observations that BSI-201 crosses the blood-brain barrier and has a mechanistic basis to synergize with t
'/>"/>

SOURCE BiPar Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2

Related medicine technology :

1. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
4. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
8. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
9. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...sia/--ChindexInternational,Inc.,("Chindex")(Nasdaq...ern,healthcareproductsandservicesinthePeople,sRepu...dthe21stAnnualPiperJaffray,"Unplugged"HealthCareCo...aceHotel. , Managementiscurrentlyscheduledtop...one-on-onemeetingsthroughouttheday.Awebcast,ofthep...
(Date:11/24/2009)...-FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRML...ndDisclosureStatementtoday,November24,2009,withthe...e.AhearingtoconsiderapprovaloftheDisclosureStateme...ringontheconfirmationofthePlanscheduledforJanuary7...msinfull.ThePlanisexpected,ifapproved,toallowholde...
(Date:11/24/2009)...ire-FirstCall/--ThoratecCorporation(Nasdaq: THOR )...pporttherapiestosave,supportandrestorefailingheart...lPiperJaffrayHealthCareConferenceonTuesday,Decembe...ieffinancialofficer,willprovideanupdateonthecompan...,PacificStandardTime). ,, Thepresentationwillbe...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Water quality in orbit 9906 1Water quality in orbit 9906 2Water quality in orbit 9906 3Water quality in orbit 9906 4Looking deeply into polymer solar cells 14009 1Looking deeply into polymer solar cells 14009 2Drug Offers Hope Against Tough to Treat Hypertension 56993 1Drug Offers Hope Against Tough to Treat Hypertension 56993 2Drug Offers Hope Against Tough to Treat Hypertension 56993 3
(Date:11/25/2009)...--DanielTouizer,CEOof Ci n e r gyHealth ,ana...nefitprograms,isconcernedthatthelabordepartment,sr...ansarewithoutafull-timejobandunlikelytohavehealthi...dbytheU-6number,whichhasspikedto17.5%,thehighestra...esestatisticsarealarmingasitmeansthatmanyAmericans...
(Date:11/25/2009)... Kaplan, MD, FACP, a former Board Chair and one of...e Los Angeles Biomedical Research Institute at Har...ed by the American College of Physicians for his l...ts April 22, 2010 meeting in Toronto, the American...h the Ralph O. Claypoole Sr. Memorial Award for De...
(Date:11/25/2009)...or patients with liver lesions, researchers find ,...- Adding the drug cetuximab to neoadjuvant chemoth...essful surgery in colorectal cancer patients with ...suggests. , , Tumors spread to other parts of ...ctal cancer. Most commonly, the cancer spreads to ...
(Date:11/25/2009)...-FirstCall/-- TheProvidenceServiceCorporation(Nas...ary,thenation,slargestcoordinatorofnon-emergencytr...fromtheStateofFloridaCommissionfortheTransportatio...ortationservicestobothMiami-DadeandVolusiaCounties...rtheinitial18monthterm,issubjecttofinalizedcontrac...
(Date:11/25/2009)...e-FirstCall/--ErnestB.Remo,Chairman/CEOof American...nnouncedtodaythatitsnewwebsitewentlive.Itincludesa...lyaccesstimelyinformationandsignuptoreceiveemailne...mericandiversifiedholdings.com ,, "Shareholder...providerelevantinformationtoshareholdersinmuchgrea...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:1 of LA BioMed's founders to be honored 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3Health News:American Diversified Holdings Corporation Announces New Website 2
...entists have been so successful in winning these a...rch being performed at Scripps Florida and in the ..., Ph.D., chairman of the department, which is loca...rkable." , The grants, from the NIH and the Depar...
...09 In a new study, published in the May issue of ....com/locate/yexnr ), scientists at the University ...monly used to treat ulcers have significant neurop... that proton pump inhibitors are also antiinflamma...
...2 April 2009 - Olivier Voinnet from the CNRS Insti...nce, is awarded the 2009 EMBO Gold Medal. The rese... on the mechanisms and roles of gene silencing via...chers in the molecular life sciences. The EMBO Gol...
...he YWCA USA will join many of its local affiliated...CA Day on April 24. This year,s theme is "Women Cr...ll advocate for an end to violence against women a... reaffirms our common commitment to world peace...
...st Widely Used PHR, Offers Convenience and Health ...aiser Permanente announced today that more than 3 ... personal health record available on www.kp.org ....zation,s personal health record an effective, easy...
...2 In celebration of Earth Day 2009, Sensitech Inc...tions, introduces a "Green Solutions" Recycling Pr...e data collection instruments for recycling. Sensi.../cgi-bin/prnh/20050209/NEW018LOGO ) , , For ma...
Other Medicine News:Health News:Scripps Research cancer biology department awarded more than $8 million in new research grants 2Health News:Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease 2Health News:Olivier Voinnet awarded 2009 EMBO Gold Medal 2Health News:Olivier Voinnet awarded 2009 EMBO Gold Medal 3Health News:Three Million People Now Using Kaiser Permanente's Personal Health Record 2Health News:Three Million People Now Using Kaiser Permanente's Personal Health Record 3Health News:Sensitech Announces 'Green Solutions' Recycling Program 2Health News:Sensitech Announces 'Green Solutions' Recycling Program 3
Richardson Retractor
Smooth Round Moderate Plus Profile Breast Implant
Advanta™ ePTFE facial implants
Chin Implants
Medicine Products: